Table 5 |
|||
|
Estimated mean costs – Per member per year |
|||
|
Cost |
Good HbA1c (≤7) |
Fair HbA1c (>7 and ≤9) |
Poor HbA1c (>9) |
|
|
|||
|
Diabetic Prescription Drugs |
$377 ($366 – $390) |
$465* ($450 – $480) |
$423* ($400 – $449) |
|
Total Diabetes Attributable Costs |
$1,505 ($1,441 – $1,571) |
$1,801* ($1,674 – $1,937) |
$1,871* ($1,684 – $2078) |
|
Sample Size |
6,069 |
3,586 |
1,125 |
|
|
|||
|
*Significant below 0.05 compared to the good control group. No differences between fair and poor control groups. Confidence intervals given in parentheses. Estimated costs from a generalized linear model with gamma as the family and logarithmic at the link and all covariates evaluated at the mean. |
|||
|
Oglesby et al. Cost Effectiveness and Resource Allocation 2006 4:1 doi:10.1186/1478-7547-4-1 |
|||
